Comment Examples of their reports (Score 1) 371
I'm an early adopter. I have used 23andMe's services and have found them enlightening, useful and thus far, accurate, in-line with other established tests that I have taken.
For those who haven't used their services before, I would recommend taking a look at the language used in their reports before being overly critical: https://www.23andme.com/health/Warfarin-Coumadin-Sensitivity/ , https://www.23andme.com/health/Breast-Cancer/
I am a reasonably rational person. I stepped into this as an early adopter, knowing that there is an unknown degree of Type I and Type II error. It has provided me with interesting results, and I have found the language used is quite clear that they are not providing a specific diagnosis or recommendation, beyond "think about" or "consider further testing on".
I am not saying that I assume most people would approach this information in the same way. I am not saying that 23andMe should be absolved of their responsibilities to due diligence and complying to regulation.
I am just saying that they do provide a very useful service that I believe will transform how we deal with prevention and wellness. As an early adopter, I hope that they (23andMe and the FDA) are able to find a balance between making this service widely available (in doing so, vastly increasing sample sizes and enabling new findings), at the same time as ensuring that people's responses to and expectations of the data provided (based on marketing claims) are sound.
For those who haven't used their services before, I would recommend taking a look at the language used in their reports before being overly critical: https://www.23andme.com/health/Warfarin-Coumadin-Sensitivity/ , https://www.23andme.com/health/Breast-Cancer/
I am a reasonably rational person. I stepped into this as an early adopter, knowing that there is an unknown degree of Type I and Type II error. It has provided me with interesting results, and I have found the language used is quite clear that they are not providing a specific diagnosis or recommendation, beyond "think about" or "consider further testing on".
I am not saying that I assume most people would approach this information in the same way. I am not saying that 23andMe should be absolved of their responsibilities to due diligence and complying to regulation.
I am just saying that they do provide a very useful service that I believe will transform how we deal with prevention and wellness. As an early adopter, I hope that they (23andMe and the FDA) are able to find a balance between making this service widely available (in doing so, vastly increasing sample sizes and enabling new findings), at the same time as ensuring that people's responses to and expectations of the data provided (based on marketing claims) are sound.
